Literature DB >> 21683359

Bacterial vaginosis as a risk factor for high-grade cervical lesions and cancer in HIV-seropositive women.

Sheri A Denslow1, Daniel J Westreich, Cynthia Firnhaber, Pam Michelow, Sophie Williams, Jennifer S Smith.   

Abstract

OBJECTIVE: To assess the effect of bacterial vaginosis (BV) on the risk of high-grade squamous intraepithelial lesions (HSIL) among HIV-seropositive women.
METHODS: A hospital-based prospective cohort study of HIV-seropositive women was conducted in Johannesburg, South Africa from January 2005 to September 2009. Multivariate log-binomial and Poisson regressions were used to estimate prevalence and rate ratios, respectively.
RESULTS: Among 1954 HIV-seropositive women, the baseline prevalence of HSIL was 17%. BV prevalence was high (54%) and showed no association with prevalence of HSIL (adjusted prevalence ratio, 1.12; 95% confidence intervals (CI), 0.92-1.35) nor with cervical lesion progression at follow-up visit (n=503) (adjusted rate ratio: 1.00; 95% CI, 0.65-1.53).
CONCLUSION: Among HIV-seropositive women, BV was not associated with an increased risk of HSIL or cervical lesion progression.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21683359     DOI: 10.1016/j.ijgo.2011.03.011

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  2 in total

1.  Characteristics of bacterial vaginosis infection in cervical lesions with high risk human papillomavirus infection.

Authors:  Huan Lu; Peng-Cheng Jiang; Xiao-Dan Zhang; Wen-Jing Hou; Zhen-Hong Wei; Jia-Qi Lu; Hao Zhang; Guang-Xu Xu; Yuan-Ping Chen; Yuan Ren; Li Wang; Rong Zhang; Ying Han
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  Individualized medicine and the microbiome in reproductive tract.

Authors:  Andrea G Braundmeier; Katherine M Lenz; Kristin S Inman; Nicholas Chia; Patricio Jeraldo; Marina R S Walther-António; Margret E Berg Miller; Fang Yang; Douglas J Creedon; Heidi Nelson; Bryan A White
Journal:  Front Physiol       Date:  2015-04-01       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.